- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 63.56M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 63.45M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 62.97M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $344K |
| Capex | Q1 2026 · Mar 31, 2025 | $529K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$35.81M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$46.89M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $66.52M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $57.22M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $21.2M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $55.59M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $95.94M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $43.12M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $196.68M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $201.26M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $182.52M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $219.94M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $217.87M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $256.85M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.58 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.65 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.58 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.65 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.71M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $10.72M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $34.97M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $39.7M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$36.77M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$41.04M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$33.44M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$42.62M |
| Revenue | Q1 2026 · Mar 31, 2026 | $20.78M |
| Revenue | Q1 2026 · Mar 31, 2025 | $13.19M |